I Platzek - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

I Platzek

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Annals of Hematology|July 24, 2012

Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantationR Ordemann, J Stöhlmacher, B Beuthien-Baumann, et al.

Magma (New York, N.Y.)|March 31, 2021

Overestimation of grey matter atrophy in glioblastoma patients following radio(chemo)therapyA Gommlich, F Raschke, J Petr, et al.

Clinical and Translational Radiation Oncology|August 15, 2022

Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapyF Raschke, K Witzmann, A Seidlitz, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Annals of Hematology|July 24, 2012

Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantationR Ordemann, J Stöhlmacher, B Beuthien-Baumann, et al.

Magma (New York, N.Y.)|March 31, 2021

Overestimation of grey matter atrophy in glioblastoma patients following radio(chemo)therapyA Gommlich, F Raschke, J Petr, et al.

Clinical and Translational Radiation Oncology|August 15, 2022

Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapyF Raschke, K Witzmann, A Seidlitz, et al.

Pageof 2